HELX Stock Price Chart
HELX Stock Price Prediction
Franklin Genomic Advancements ETF
$40.36
-0.95%
$-0.39
At close: Aug 14, 16:00:00 GMT-4
$40.5
0.34%
$0.14
Post-market: Aug 14, 20:00:00 GMT-4
Back
Franklin Genomic Advancements ETF (HELX) Stock Price Prediction
HELX Stock Price Prediction Summary
HELX stock price ended at $40.75 on Thursday, after dropping 1.57%
On the latest trading day Aug 13, 2026, the stock price of HELX fell by 1.57%, dropping from $41.20 to $40.75. During the session, the stock saw a volatility of 1.10%, with prices oscillating between a daily low of $40.75 and a high of $41.20. On the latest trading day, the trading volume for HELX decreased by 597 shares, aligning with the declining prices, which may indicate weakening market confidence in the near term. In total, 523 shares were traded, with a market value of approximately $30.6M.
HELX Technical Signals
Technical Signals Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
HELX currently exhibits 4 buy signals and 2 sell signals. The stock has been in an downtrend since 12:00 AM, with a total price change of -2.35% during this period. Overall, the technical indicators point to a Buy outlook for the mid-term.
Bullish/Bearish Signals for HELX
Our algorithms analyze key indicators like moving averages, RSI, MACD, and trading volume to generate bullish and bearish signals for HELX. These insights help you make informed investment decisions.
Key Stats
Prev.Close
$40.75
Open
$40.38
Day's Range
$40.36 - $40.5
52 week range
$27.59 - $41.32
Volume
1.7K
Avg.Volume
360
Dividend yield
0.45%
Net Assets
$0
NAV
--
Expense Ratio
--
Shares Outstanding
752.5K
What is HELX?
HELX was created on 2020-02-25 by Franklin. The fund's investment portfolio concentrates primarily on theme equity. The ETF currently has 29.76m in AUM and 62 holdings. HELX is an actively managed portfolio of global equity securities of companies relevant to genomic discovery.
